CAT No: CP25356
CAS No:144978-12-1
Synonyms/Alias:boc-pyr-oet;144978-12-1;(s)-ethyl-n-boc-pyroglutamate;N-Boc-L-pyroglutamicacidethylester;1-Boc-L-Pyroglutamicacidethylester;Boc-L-Pyroglutamicacidethylester;(S)-1-TERT-BUTYL2-ETHYL5-OXOPYRROLIDINE-1,2-DICARBOXYLATE;(S)-5-OXO-PYRROLIDINE-1,2-DICARBOXYLICACID1-TERT-BUTYLESTER2-ETHYLESTER;1,2-Pyrrolidinedicarboxylicacid,5-oxo-,1-(1,1-dimethylethyl)2-ethylester,(2S)-;1-(tert-butyl)2-ethyl(S)-5-oxopyrrolidine-1,2-dicarboxylate;AC1NUUBP;PubChem12120;BOC-L-PYR-OET;EthylBoc-L-pyroglutamate;EthylN-Boc-L-pyroglutamate;(S)-N-alpha-t-Butyloxycarbonyl-pyroglutamicacidethylester;EthylN-Boc(S)-pyroglutamate;SCHEMBL903617;(s)-ethyln-boc-pyroglutamate;UPCMLD00WCRH2-043;PYR231;Jsp002635;1-TERT-BUTYL2-ETHYL(2S)-5-OXOPYRROLIDINE-1,2-DICARBOXYLATE;N-Boc-L-pyroglutamicAcidEthyl;MolPort-000-002-216
Chemical Name:(S)-N-alpha-t-Butyloxycarbonyl-pyroglutamic acid ethyl ester
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.